@pharmaphorum.bsky.socialA #consumeradvocacygroup has scrutinised some of the #MostFavouredNation (MFN) #pricing deals the #Trump administration has announced with 27 #pharma companies and concludes that claims about the savings they deliver are smoke and mirrors.
@cancerpatientseu.bsky.social📢 Pricing decisions taken outside Europe are already shaping when new cancer treatments reach European patients.
Our Policy Statement on #MostFavouredNation drug pricing is now open for endorsement.
đź”— Add your organisation's voice: lnkd.in/extc5AST
@4040rec.bsky.social